Braveheart Bio (BRVE) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 5

8 insiders bought $89.2M. No sales.

BuyAH BIO Fund IV, L.P.$19.8M10% ownerat $18.00 on Aug 7, filed Aug 11

BuyAH BIO Fund IV, L.P.10% owner$19.8Mat $18.00 on Aug 7, filed Aug 11

BuyForbion Growth Opportunities Fund III Cooperatief U.A.$34.6M10% ownerat $18.00 on Aug 7, filed Aug 7

BuyForbion Growth Opportunities Fund III Cooperatief U.A.10% owner$34.6Mat $18.00 on Aug 7, filed Aug 7

BuyForbion Growth Opportunities Fund III Cooperatief U.A.$30.2M10% ownerat $18.00 on Aug 7, filed Aug 7

BuyForbion Growth Opportunities Fund III Cooperatief U.A.10% owner$30.2Mat $18.00 on Aug 7, filed Aug 7

From SEC Form 4s, the newest filed Aug 11, 2026 · Insiders have 2 business days to file a trade

6 more filings on BRVE in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on BRVE with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Braveheart Bio

Insider trades by person

Cluster buys at BRVE

8 insiders bought BRVE in the last 6 months: Forbion Growth Opportunities Fund III Cooperatief U.A., AH BIO Fund IV, L.P., Christopher Viehbacher, Travis Murdoch, David Charles Lubner, James Paul Rickey, David I. Malek, and Michele A. Anderson.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about BRVE's insider trades

As of Oct 26, 2026: Braveheart Bio (BRVE) has 9 insider filings on record in the last 6 months, the newest filed Aug 11, 2026. Its Quality Score is 5 (Below Average). Scores as of 10:16 PM ET, 15 minutes behind.

Are BRVE insiders buying or selling?

8 insiders bought $89.2M across 9 filings in the last 6 months. No open-⁠market sales on record. The newest filing: AH BIO Fund IV, L.P., 10% owner, bought $19.8M on Aug 7, 2026. 8 insiders bought BRVE in the last 6 months: Forbion Growth Opportunities Fund III Cooperatief U.A., AH BIO Fund IV, L.P., Christopher Viehbacher, Travis Murdoch, David Charles Lubner, James Paul Rickey, David I. Malek, and Michele A. Anderson.

Who are BRVE's biggest insider sellers?

No BRVE insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did a BRVE insider last buy?

AH BIO Fund IV, L.P., 10% owner, bought BRVE shares ($19.8M) on Aug 7, 2026, filed Aug 11, 2026, the newest insider buy on record.

Braveheart Bio's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. BRVE is on insider buys, Aug 10 to 16, 2026.